JOUNCE THERAPEUTICS INC - COM (JNCE)

Historical Institutional Holders from Q1 2017 to Q3 2023

All holders as of September 30, 2023
Q3 2023
Type / Class
Equity / COM
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2023 Q3 0 $0 -$918K 0
2023 Q2 670K $918K -$58.1M $1.37 1
2023 Q1 32.8M $60.6M +$5.67M $1.85 82
2022 Q4 34.4M $38.2M -$14.4M $1.11 80
2022 Q3 41.7M $97.6M -$1.76M $2.34 94
2022 Q2 41.8M $127M -$9.67M $3.03 97
2022 Q1 41.5M $282M +$4.11M $6.79 109
2021 Q4 40.4M $337M +$8.31M $8.35 121
2021 Q3 35.6M $265M +$3.53M $7.43 109
2021 Q2 35.3M $240M -$13.8M $6.80 123
2021 Q1 36.2M $372M +$98.1M $10.27 117
2020 Q4 27.2M $190M +$12.7M $7.00 98
2020 Q3 24.8M $203M -$4.94M $8.16 96
2020 Q2 25.5M $176M -$1.39M $6.90 89
2020 Q1 25.8M $123M +$711K $4.75 86
2019 Q4 24.6M $215M +$18.5M $8.73 95
2019 Q3 23.4M $78.1M -$3.2M $3.33 74
2019 Q2 24M $119M -$28.1K $4.95 77
2019 Q1 24.2M $150M +$2.51M $6.20 77
2018 Q4 24M $80.7M -$11.5M $3.37 79
2018 Q3 27M $176M -$3.14M $6.50 83
2018 Q2 27.4M $210M -$80.8M $7.66 81
2018 Q1 29.4M $429M +$26.5M $22.35 93
2017 Q4 29.2M $373M +$6.71M $12.75 82
2017 Q3 15.3M $239M +$20.9M $15.58 74
2017 Q2 14M $195M +$14.8M $14.03 71
2017 Q1 12.7M $270M +$270M $21.99 59